65 related articles for article (PubMed ID: 38615173)
1. [New insight into DNA methylation in CML and its effect on clinical outcome--review].
Tang Y; Hu JP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1482-6. PubMed ID: 19099669
[TBL] [Abstract][Full Text] [Related]
2. Clinical applications of abnormal DNA methylation in chronic myeloid leukemia.
Zhou L; Yin X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 49(1):122-127. PubMed ID: 38615173
[TBL] [Abstract][Full Text] [Related]
3. Aberrant DNA Methylation in Chronic Myeloid Leukemia: Cell Fate Control, Prognosis, and Therapeutic Response.
Behzad MM; Shahrabi S; Jaseb K; Bertacchini J; Ketabchi N; Saki N
Biochem Genet; 2018 Jun; 56(3):149-175. PubMed ID: 29388070
[TBL] [Abstract][Full Text] [Related]
4. Aberrant DNA methylation at HOXA4 and HOXA5 genes are associated with resistance to imatinib mesylate among chronic myeloid leukemia patients.
Elias MH; Azlan H; Sulong S; Baba AA; Ankathil R
Cancer Rep (Hoboken); 2018 Aug; 1(2):e1111. PubMed ID: 32721103
[TBL] [Abstract][Full Text] [Related]
5. Methylation status of DDIT3 gene in chronic myeloid leukemia.
Wang YL; Qian J; Lin J; Yao DM; Qian Z; Zhu ZH; Li JY
J Exp Clin Cancer Res; 2010 May; 29(1):54. PubMed ID: 20492726
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34
Maupetit-Mehouas S; Court F; Bourgne C; Guerci-Bresler A; Cony-Makhoul P; Johnson H; Etienne G; Rousselot P; Guyotat D; Janel A; Hermet E; Saugues S; Berger J; Arnaud P; Berger MG
Mol Oncol; 2018 Jun; 12(6):814-829. PubMed ID: 29575763
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of human DNA methylation, alteration of methylation patterns in physiological processes and oncology.
Sergeeva A; Davydova K; Perenkov A; Vedunova M
Gene; 2023 Jul; 875():147487. PubMed ID: 37211289
[TBL] [Abstract][Full Text] [Related]
8. Aberrant DNA Methylation Status and mRNA Expression Level of SMG1 Gene in Chronic Myeloid Leukemia: A Case-Control Study.
Hojjatipour T; Sohani M; Maali A; Rostami S; Azad M
Cell J; 2022 Dec; 24(12):757-763. PubMed ID: 36527348
[TBL] [Abstract][Full Text] [Related]
9. Mammalian DNA methylome dynamics: mechanisms, functions and new frontiers.
Wei A; Wu H
Development; 2022 Dec; 149(24):. PubMed ID: 36519514
[TBL] [Abstract][Full Text] [Related]
10. Management of TKI-resistant chronic phase CML.
Hughes TP; Shanmuganathan N
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):129-137. PubMed ID: 36485117
[TBL] [Abstract][Full Text] [Related]
11. SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemia.
Wu DL; Wang Y; Zhang TJ; Chu MQ; Xu ZJ; Yuan Q; Ma JC; Lin J; Qian J; Zhou JD
Eur J Med Res; 2022 Nov; 27(1):259. PubMed ID: 36411451
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of DNA Methylation.
Lopez M; Gilbert J; Contreras J; Halby L; Arimondo PB
Adv Exp Med Biol; 2022; 1389():471-513. PubMed ID: 36350520
[TBL] [Abstract][Full Text] [Related]
13. DNMT and EZH2 inhibitors synergize to activate therapeutic targets in hepatocellular carcinoma.
Zhang L; Li HT; Shereda R; Lu Q; Weisenberger DJ; O'Connell C; Machida K; An W; Lenz HJ; El-Khoueiry A; Jones PA; Liu M; Liang G
Cancer Lett; 2022 Nov; 548():215899. PubMed ID: 36087682
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
